# Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD

> **NCT04050449** · — · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 1339 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04050449
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-28
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 1339 (ACTUAL)
- **Last updated:** 2023-08-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04050449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04050449, "Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04050449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*